Corporate Responsibility Report

Overview

The report presents Relay Therapeutics' fourth comprehensive responsibility disclosure for 2023. It highlights progress across three clinical-stage programs, continued investment in employees, and operations across two Cambridge sites. The company also reports 5,987,234 kWh of total energy consumed and describes its initial climate-related risk assessment and TCFD-aligned governance.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services